Both in Pharmaceuticals
Spruce Biosciences vs MacroGenics
Over the past year SPRB returned −59.1% and MGNX returned +47.5%; their daily moves had a correlation of 0.17.
SPRB −59.1% MGNX +47.5%Growth of $1, one year, split-adjusted
| Metric | SPRB | MGNX |
|---|---|---|
| Price | $42.81 | $2.33 |
| Market cap | $123.0M | $148.4M |
| Today | −3.91% | 0.00% |
| 1 month | −5.7% | −38.2% |
| 6 months | −27.9% | −26.0% |
| Year to date | −50.9% | +44.7% |
| 1 year | −61.1% | +40.4% |
| Revenue growth (YoY) | — | +378.0% |
| Gross margin | — | 100.0% |
| Net margin | — | 59.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $89.2M | $173.3M |
| Dividend yield | — | — |
| Volatility (60d) | 64.5% | 113.8% |
| Short % of float | 22.4% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).